Pyxis Oncology, Inc.
PYXS
$3.37
-$0.63-15.75%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -22.00M | -18.35M | -21.16M | -35.57M | -21.20M |
| Total Depreciation and Amortization | 527.00K | 535.00K | 552.00K | 550.00K | 731.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 2.75M | 2.32M | 2.67M | 22.39M | 1.51M |
| Change in Net Operating Assets | 5.45M | -1.77M | -4.60M | -6.66M | 4.30M |
| Cash from Operations | -13.28M | -17.26M | -22.54M | -19.29M | -14.67M |
| Capital Expenditure | -9.00K | -- | -- | 0.00 | 0.00 |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 11.48M | 15.30M | 15.82M | 26.66M | -8.00K |
| Cash from Investing | 11.47M | 15.30M | 15.82M | 26.66M | -8.00K |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 0.00 | 0.00 | 2.00K | -- | 1.66M |
| Repurchase of Common Stock | -8.00K | -67.00K | -2.00K | -7.65M | -1.00K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | 7.70M | -- |
| Cash from Financing | -8.00K | -67.00K | 0.00 | 50.00K | 1.66M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -1.81M | -2.03M | -6.71M | 7.42M | -13.02M |